lobbying_activities: 2824163
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2824163 | 1979df22-1a58-42c4-9f86-5a424bfb1565 | Q2 | STRATEGIES 360 | 79175 | INNOVA MEDICAL GROUP, INC. | 2022 | second_quarter | MED | Issues relating to the FDA approval process for medical testing | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2022-07-18T13:10:02-04:00 |